Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.
about
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Serial immunological parameter ...... ceptor-positive breast cancer.
@en
Serial immunological parameter ...... ceptor-positive breast cancer.
@nl
type
label
Serial immunological parameter ...... ceptor-positive breast cancer.
@en
Serial immunological parameter ...... ceptor-positive breast cancer.
@nl
prefLabel
Serial immunological parameter ...... ceptor-positive breast cancer.
@en
Serial immunological parameter ...... ceptor-positive breast cancer.
@nl
P2093
P2860
P50
P1476
Serial immunological parameter ...... ceptor-positive breast cancer.
@en
P2093
Alyssa Iwano
Bahar Budan
Derya Unutmaz
Ece Tavukcuoglu
James Speyer
Jennifer Wu
Komal Jhaveri
Lina Kozhaya
Marleen Meyers
Maryam Bonakdar
P2860
P2888
P356
10.1007/S10549-017-4570-4
P407
P577
2017-11-09T00:00:00Z